Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-03
2007-07-03
Wilson, James O. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S468000
Reexamination Certificate
active
10376385
ABSTRACT:
The present invention provides eletriptan hydrobromide monohydrate of the formula (I):together with processes for preparing, uses of, and compositions containing, said monohydrate.
REFERENCES:
patent: 3952741 (1976-04-01), Baker
patent: 5112621 (1992-05-01), Stevens et al.
patent: 5464633 (1995-11-01), Conte et al.
patent: 5474784 (1995-12-01), Stevens et al.
patent: 5545644 (1996-08-01), Macor et al.
patent: 5712300 (1998-01-01), Jacobsen
patent: 5994387 (1999-11-01), Wythes
patent: 6110940 (2000-08-01), Harding et al.
patent: WO 92/06973 (1992-04-01), None
patent: WO 96/06842 (1996-03-01), None
patent: WO 98/27089 (1998-06-01), None
patent: WO 98/39327 (1998-09-01), None
patent: WO 99/01135 (1999-01-01), None
Jones et al., Pharmacology, Biochemistry and Behaviour 71, (2002) 555-568, Medical benefit of 5-HT-research.
Robichaud et al., Annual Reports in Medicinal Chemistry, 200, 11-20, 35.
Dallman Christopher Ian
Ogilvie Ronald James
Ashbrook Charles W.
Kurlandsky David R.
Pfizer Inc.
Sackey Ebenezer
Wilson James O.
LandOfFree
Indole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3792839